- Home
- DAC vs VRDN Comparison
DAC vs VRDN Comparison
Compare DAC & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAC
- VRDN
- Stock Information
- Founded
- DAC 1972
- VRDN 2006
- Country
- DAC Greece
- VRDN United States
- Employees
- DAC N/A
- VRDN N/A
- Industry
- DAC Marine Transportation
- VRDN Medical Specialities
- Sector
- DAC Consumer Discretionary
- VRDN Health Care
- Exchange
- DAC Nasdaq
- VRDN Nasdaq
- Market Cap
- DAC 1.6B
- VRDN 1.6B
- IPO Year
- DAC 2006
- VRDN N/A
- Fundamental
- Price
- DAC $83.12
- VRDN $15.93
- Analyst Decision
- DAC Strong Buy
- VRDN Buy
- Analyst Count
- DAC 1
- VRDN 12
- Target Price
- DAC $105.00
- VRDN $36.44
- AVG Volume (30 Days)
- DAC 106.7K
- VRDN 954.2K
- Earning Date
- DAC 02-10-2025
- VRDN 03-04-2025
- Dividend Yield
- DAC 4.11%
- VRDN N/A
- EPS Growth
- DAC N/A
- VRDN N/A
- EPS
- DAC 26.05
- VRDN N/A
- Revenue
- DAC $1,014,110,000.00
- VRDN $302,000.00
- Revenue This Year
- DAC $4.23
- VRDN $3.30
- Revenue Next Year
- DAC N/A
- VRDN N/A
- P/E Ratio
- DAC $3.25
- VRDN N/A
- Revenue Growth
- DAC 4.16
- VRDN N/A
- 52 Week Low
- DAC $69.33
- VRDN $11.40
- 52 Week High
- DAC $98.25
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- DAC 55.07
- VRDN 34.52
- Support Level
- DAC $81.99
- VRDN $15.62
- Resistance Level
- DAC $86.60
- VRDN $16.97
- Average True Range (ATR)
- DAC 1.81
- VRDN 0.90
- MACD
- DAC 0.32
- VRDN -0.19
- Stochastic Oscillator
- DAC 56.26
- VRDN 6.90
About DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.